Words of wisdom: Re: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial

Eur Urol. 2014 May;65(5):1012. doi: 10.1016/j.eururo.2013.12.039.

Authors

Roman Sosnowski¹, Jerzy Zawistowski²

Affiliations

¹ Department of Urology, M. Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. Electronic address: roman@is.com.pl.
² Food, Nutrition and Health, University of British Columbia, Vancouver, BC, Canada.

PMID: 24646497
DOI: 10.1016/j.eururo.2013.12.039

No abstract available

Publication types

Comment

MeSH terms

Fatty Acids, Omega-3 / adverse effects*
Fatty Acids, Omega-3 / blood*
Fatty Acids, Omega-6 / blood*
Humans
Male
Prostatic Neoplasms / diagnosis*
Prostatic Neoplasms / epidemiology*

Substances

Fatty Acids, Omega-3
Fatty Acids, Omega-6